Insider Transactions in Q4 2022 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2022
|
Kathleen D. Scott Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
8,250
+50.0%
|
$49,500
$6.24 P/Share
|
|
Nov 09
2022
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
43,896
-17.27%
|
$175,584
$4.58 P/Share
|
|
Nov 08
2022
|
Rajeev Dadoo |
BUY
Grant, award, or other acquisition
|
Indirect |
3,009,677
+50.0%
|
-
|
|
Nov 08
2022
|
Michael Kelly |
BUY
Grant, award, or other acquisition
|
Indirect |
83,225
+50.0%
|
-
|
|
Nov 08
2022
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
7,872,554
+50.0%
|
-
|
|
Nov 08
2022
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,176,822
+50.0%
|
-
|
|
Nov 08
2022
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
7,872,554
+50.0%
|
-
|
|
Nov 08
2022
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,326,854
+50.0%
|
-
|
|
Nov 08
2022
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
3,009,678
+50.0%
|
-
|
|
Nov 08
2022
|
Pratik Shah |
BUY
Grant, award, or other acquisition
|
Indirect |
10,156,204
+50.0%
|
-
|
|
Nov 08
2022
|
Justin Chakma Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236,380
+50.0%
|
-
|